No Data
No Data
Dalian Bio-Chem (603360.SH): Signed the "Semiconductors Equipment Business Cooperation Settlement Agreement" with Xinhui Lian.
On December 24, Gelonghui reported that Dalian Bio-Chem (603360.SH) announced that on February 7, 2024, it signed a "Semiconductor Equipment Business Cooperation Agreement" with Suzhou Xinhuilian Semiconductor Technology Co., Ltd. (referred to as "Xinhuilian"), agreeing to cooperate in the semiconductor equipment business. As of the date of this announcement, the company controls 54.6342% of the voting rights of Xinhuilian and has included Xinhuilian in its consolidated financial statements. Therefore, the company no longer needs to conduct semiconductor equipment-related business with Xinhuilian through business cooperation. Thus, the company has signed the "Semiconductor Equipment Business Cooperation Settlement Agreement" with Xinhuilian regarding.
Dalian BIO-CHEM (SHSE:603360) Will Want To Turn Around Its Return Trends
Is Dalian BIO-CHEM Company Limited's (SHSE:603360) Latest Stock Performance A Reflection Of Its Financial Health?
Dalian BIO-CHEM PLans 10-Million-Yuan Investment in Semiconductor Industry
Dalian bio-chem (603360.SH): Plans to establish a wholly-owned subsidiary with 10 million yuan for further investment in the semiconductor industry.
On November 25, Gelonghui reported that dalian bio-chem (603360.SH) announced its plan to establish a wholly-owned subsidiary with an investment of 10 million yuan in cash, aimed at achieving the company's global strategy objectives and development needs, optimizing structure, and controlling risks, for further investments in the semiconductors industry. This external investment to establish a wholly-owned subsidiary is to meet the company's future needs for further private equity investments in Suzhou Chipwise Semiconductor Technology Co., Ltd., and Chipwise New (Suzhou) Technology Co., Ltd. and its affiliates, continuing to expand the company's strategic layout in the fields of semiconductor materials, consumables, and equipment, and increase and enhance the company.
Dalian BIO-CHEM's (SHSE:603360) Earnings Growth Rate Lags the 53% CAGR Delivered to Shareholders